Litigation Details for Genentech, Inc v. JHL Biotech, Inc. (N.D. Cal. 2018)
✉ Email this page to a colleague
Genentech, Inc v. JHL Biotech, Inc. (N.D. Cal. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-10-29 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 18:1836(b) - Civil Action to Protect Trade Secrets | Assigned To | William Haskell Alsup |
Jury Demand | Both | Referred To | Sallie Kim |
Patents | 9,226,961 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Genentech, Inc v. JHL Biotech, Inc.
Details for Genentech, Inc v. JHL Biotech, Inc. (N.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-01-04 | 77 | Opposition/Response to Motion | various publications, including Genentech US patent 9,226,961. (See 2 id. ¶154.) And …annually as of 2013 have recently lost patent protection or will lose patent protection 20 in the next few…Biosimilars are enabled by the expiration of numerous patents and by changes 18 to the pathway for regulatory…competing products as soon as the reference drugs’ patents expire, it is important for JHL 3 to seek regulatory…following the Supreme Court’s rejection of it in the patent context. eBay 20 Inc. v. MercExchange, L.L.C. | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |